日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Downregulation of ANPEP Is Associated with Aggressive Prostate Cancer and Poor Disease-specific Outcomes

ANPEP表达下调与侵袭性前列腺癌和不良疾病特异性预后相关

Putney, Ryan M; Trivedi, Purvish; Awasthi, Shivanshu; Serna, Amparo; Dhillon, Jasreman; Sweeney, Christopher J; Jeffrey Karnes, R; Cooperberg, Matthew R; Berlin, Alejandro; Nguyen, Paul L; Spratt, Daniel E; Davicioni, Elai; Proudfoot, James; Ryu, Monica; Katende, Esther; Park, Jong Y; Rebbeck, Timothy R; El-Kenawi, Asmaa; Yamoah, Kosj

Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST)

50基因微阵列预测分析(PAM50)分类器已验证可用于预测前列腺癌在主动监测中的进展:迈阿密主动监测试验(MAST)

Malpani, Ankur; Ryan, Jonathan T; Yu, Hui; Soodana-Prakash, Nachiketh; Khandekar, Archan; Ajami, Tarek; Williams, Adam; Szczotka, Zoe; Alshalalfa, Mohammed; Hao, Yangyang; Davicioni, Elai; Swain, Sanjaya; Kryvenko, Oleksandr N; Pra, Alan Dal; Stoyanova, Radka; Gaston, Sandra; Pollack, Alan; Mahal, Brandon A; Abramowitz, Matthew; Nahar, Bruno; Ritch, Chad R; Kava, Bruce; Gonzalgo, Mark L; Parekh, Dipen J; Punnen, Sanoj

Tertiary lymphoid structures in genitourinary cancers: a comprehensive review

泌尿生殖系统肿瘤的三级淋巴结构:一项综合综述

Abreu, Alvaro; Viera Plasencia, Alejandra; Iribarren, Mercy; Wegner, Carter; Nuraj, Joana; Davicioni, Elai; Bahmad, Hisham F; Shahait, Mohammed

The role of HAI-1 in urothelial bladder cancer: Tissue expression, ectodomain shedding and clinical outcomes

HAI-1在尿路上皮膀胱癌中的作用:组织表达、胞外域脱落和临床结果

Saeed, Azad K; Triantafyllakis, Panagiotis; Gordon, Naheema S; James, Nicholas D; Zeegers, Maurice P; Cheng, K K; de Jong, Joep J; Davicioni, Elai; Bryan, Richard T; Ward, Douglas G

Spatial multi-omics identifies aggressive prostate cancer signatures highlighting pro-inflammatory chemokine activity in the tumor microenvironment.

空间多组学识别出侵袭性前列腺癌的特征,突显了肿瘤微环境中的促炎趋化因子活性。

Krossa Sebastian, Andersen Maria K, Sandholm Elise M, Wess Maximilian, Kiviaho Antti, Sharma Abhibhav, Hakkola Sini, Hao Yangyang, Alshalalfa Mohammed, Davicioni Elai, Viset Trond, Størkersen Øystein, Karnes R Jeffrey, Spratt Daniel E, Giskeødegård Guro F, Nykter Matti, Rye Morten B, Urbanucci Alfonso, Tessem May-Britt

Transcriptomic Profiling of the Tumor Immune Microenvironment Reveals Prognostic Markers in mCRPC Patients Treated with LuPSMA Therapy

肿瘤免疫微环境转录组分析揭示了接受 LuPSMA 疗法治疗的转移性去势抵抗性前列腺癌患者的预后标志物

Handke, Analena; Lopes, Leonor; Kesch, Claudia; Darr, Christopher; Davicioni, Elai; Shi, Kuangyu; Telli, Tugce; Fendler, Wolfgang P; Herrmann, Ken; Lückerath, Katharina; Hadaschik, Boris; Seifert, Robert

Transcriptomic predictors of prostate cancer recurrence following focal cryotherapy: a pooled analysis of phase II trial and prospective cohort data

前列腺癌局部冷冻治疗后复发的转录组预测因子:II期临床试验和前瞻性队列数据的汇总分析

Tay, Kae Jack; Hong, Boon Hao; Ong, Enya Hui Wen; Tan, Kah Min; Pacho, Gianella Cabuhat; Wong, Samantha Jingxuan; Tan, Yu Guang; Law, Yan Mee; Ngo, Nye Thane; Tan, Puay Hoon; Yuen, John S P; Ho, Henry S S; Chen, Kenneth; Peng, Jiping; Foo, Clare Wei Tian; Sam, Xin Xiu; Tuan, Jeffrey K L; Kanesvaran, Ravindran; Gupta, Rajan T; Rozen, Steven; Polascik, Thomas J; Liu, Yang; Proudfoot, James; Davicioni, Elai; Khor, Li Yan; Chua, Melvin Lee Kiang

A Randomized Controlled Phase 2 Trial Comparing Salvage Radiotherapy for Prostate Cancer Delivered in 4 Versus 2 Weeks (SHORTER): Acute Genitourinary and Gastrointestinal Patient-reported Outcomes at a Single Institution

一项随机对照 II 期试验比较了 4 周与 2 周内完成的挽救性放疗治疗前列腺癌的效果(SHORTER):单中心患者报告的急性泌尿生殖系统和胃肠道不良反应结局

Nagar, Himanshu; Diven, Marshall A; Rippon, Brady; Barbieri, Christopher E; Hu, Jim C; Scherr, Douglas S; Yadav, Pragya; Tshering, Lhaden; Chandrasekhar, Sharanya; Wolfe, Sydney; Pennell, Ryan; Coonce, Madeline; Chen, Shu Ling; Formenti, Silvia C; Strong, Paul; Davicioni, Elai; Molina, Ana M; Nanus, David M; Nauseef, Jones T; Sternberg, Cora N; Zhou, Xi K; Lei, Wanna; Osborne, Joseph R; Marciscano, Ariel E; Tagawa, Scott T

Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial

NRG Oncology/RTOG 0521 3期试验表明,局部高危前列腺癌的转录组分析可改善预后,并揭示在根治性放疗联合雄激素抑制治疗中加入多西他赛的益处。

Phillips, Ryan M; Proudfoot, James A; Davicioni, Elai; Liu, Yang; Spratt, Daniel E; Simko, Jeff M; Den, Robert B; Pollack, Alan; Rosenthal, Seth A; Sartor, A Oliver; Sweeney, Christopher J; Attard, Gerhardt; Longoria, Leslie; Patel, Samir; Straza, Michael W; Efstathiou, Jason A; Shah, Amit B; Hoffman, Karen E; Rodgers, Joseph P; Sandler, Howard M; Feng, Felix Y; Tran, Phuoc T

Androgen receptor splice variant expression and prostate cancer recurrence after salvage therapy

雄激素受体剪接变体表达与挽救治疗后前列腺癌复发

Konieczkowski, David J; Otani, Keisuke; Guan, Zoe; Drumm, Michael R; Otani, Yukako; Badusi, Priscilla Oluwakemi; Chung, Ella H; Wu, Shulin; Davicioni, Elai; Saylor, Philip J; Wu, Chin-Lee; Efstathiou, Jason A; Miyamoto, David T